Metraipolis › archive › dc_84e7df583363
Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer — Europe PMC PMID:41221278
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41221278
- DOI
- 10.3389/fimmu.2025.1656593
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T00:55:26.952Z
- SHA-256 of the archived text
5e064d49a1a08d1605a15f0f9f30e62a0c6207401dcc7b811266b8852c424773- Stable URL of this page
https://metraipolis.com/documento/dc_84e7df583363
How to cite
Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer — Europe PMC PMID:41221278 — Europe PMC (en), https://europepmc.org/article/MED/41221278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_84e7df583363 (Metraipolis archive dc_84e7df583363, sha256 5e064d49a1a08d1605a15f0f9f30e62a0c6207401dcc7b811266b8852c424773)
BibTeX
@misc{dc84e7df583363,
title = {Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer — Europe PMC PMID:41221278},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41221278},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_84e7df583363; sha256 5e064d49a1a08d1605a15f0f9f30e62a0c6207401dcc7b811266b8852c424773},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41221278. Agents can read the archived copy with the MCP tool read_document.